Honasa Consumer Acquires 58% Stake In Fluence Pharma For Rs 135 Crore

Why Did Honasa Consumer Acquire Fluence Pharma?

Honasa Consumer, the parent company of Mamaearth, has acquired a 58% stake in nutraceuticals company Fluence Pharma at an enterprise valuation of approximately Rs 135 crore. The acquisition marks Honasa’s entry into India’s rapidly growing nutraceuticals and wellness segment as it seeks to diversify beyond beauty and personal care products.

The company will acquire the remaining 42% stake in Fluence Pharma through two separate tranches over the next five to seven years, strengthening its long-term commitment to the health and wellness category.

How Will Honasa Expand Its Presence In The Nutraceuticals Market?

As part of the acquisition, Honasa Consumer will establish a wholly owned subsidiary named Honasa Health, which will focus on building a direct-to-consumer nutraceuticals business.

The company plans to combine Fluence Pharma’s scientific expertise, dermatologist network, and product innovation capabilities with Honasa’s strengths in brand building, digital marketing, and distribution.

The move aligns with Honasa’s broader strategy of expanding into science backed wellness products amid rising consumer interest in preventive healthcare and nutritional supplementation.

Bharti Airtel Raises Airtel Africa Stake To 79% In ₹28,000 Crore Deal

What Does Fluence Pharma Bring To Honasa’s Portfolio?

Founded in 2012 by Amit Bhusari and Dr. Rajendra Singh Rajput, Fluence Pharma specializes in hair and skin health supplements marketed through dermatologists.

The company operates brands including Hair Fact, Skin Fact, and Pro Fact and has built a nationwide network of more than 3,000 dermatologists. It is also known for its proprietary Cyclical Nutrition Therapy (CNT) platform, which focuses on addressing nutritional deficiencies linked to hair and skin concerns.

This strong practitioner-led distribution model provides Honasa with access to a specialized and trusted healthcare channel.

Why Is The Nutraceuticals Industry Becoming Attractive?

The acquisition comes at a time when India’s nutraceuticals industry is witnessing strong growth. According to Honasa, the domestic nutraceuticals market is valued at more than Rs 16,000 crore and continues to expand rapidly.

Consumers are increasingly adopting “inside-out” beauty solutions, where nutrition-based products complement skincare and personal care routines. This trend has created significant opportunities for brands operating at the intersection of beauty, wellness, and healthcare.

Honasa believes that science-backed supplements will become a key growth driver in the evolving wellness landscape.

How Strong Is Fluence Pharma’s Business Performance?

Fluence Pharma reported revenue of approximately Rs 40 crore in FY26 and maintained an EBITDA margin exceeding 20%, according to company disclosures.

More than 70% of the company’s revenue comes from hair-focused products, making it a strong player in one of India’s fastest-growing wellness segments.

The company’s profitable operations and established dermatologist network were key factors supporting the acquisition.

What Does This Deal Signal For India’s D2C Beauty And Wellness Sector?

The Fluence Pharma acquisition marks Honasa Consumer’s second strategic acquisition in the past six months. In December 2025, the company entered the men’s grooming segment through the acquisition of Reginald Men.

The transaction also highlights the ongoing consolidation within India’s D2C beauty, wellness, and nutrition ecosystem. Several consumer companies have acquired digital-first brands to strengthen their market positions and enter new growth categories.

Recent deals include L’Oréal’s acquisition of Innovist, HUL’s acquisition of Oziva and Minimalist, USV’s acquisition of Wellbeing Nutrition, and Marico’s investments in Cosmix and 4700BC.

As competition intensifies and consumer preferences evolve, acquisitions are increasingly becoming a preferred strategy for companies looking to expand into high-growth wellness categories.